A new study finds that statin use significantly improves survival outcomes in patients with chronic lymphocytic leukemia or ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

Here, we demonstrate that STAT3 activation mostly results from constitutive Janus kinase (JAK)3 phosphorylation on tyrosine 980 ... a major role in NKCL cell growth and survival and in the ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

These compounds have been well characterized for efficacy against the mutant enzymes ... of ABL tyrosine kinase activity 70. GNF-2 inhibits the proliferation of Ba/F3 cells transfected with ...

Tyrosine kinase inhibitors ... cellular proliferation, promotion of apoptosis, and inhibition of anti-angiogenesis. Gefitinib has demonstrated significant efficacy in non-small-cell lung cancer ...